- Home
- SPRO vs TOPP Comparison
SPRO vs TOPP Comparison
Compare SPRO & TOPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRO
- TOPP
- Stock Information
- Founded
- SPRO 2013
- TOPP 2014
- Country
- SPRO United States
- TOPP United States
- Employees
- SPRO N/A
- TOPP N/A
- Industry
- SPRO Biotechnology: Pharmaceutical Preparations
- TOPP
- Sector
- SPRO Health Care
- TOPP
- Exchange
- SPRO Nasdaq
- TOPP NYSE
- Market Cap
- SPRO 33.0M
- TOPP 26.6M
- IPO Year
- SPRO 2017
- TOPP 2025
- Fundamental
- Price
- SPRO $3.02
- TOPP $1.79
- Analyst Decision
- SPRO Buy
- TOPP
- Analyst Count
- SPRO 4
- TOPP 0
- Target Price
- SPRO $5.00
- TOPP N/A
- AVG Volume (30 Days)
- SPRO 12.5M
- TOPP 18.1K
- Earning Date
- SPRO 08-04-2025
- TOPP 08-11-2025
- Dividend Yield
- SPRO N/A
- TOPP N/A
- EPS Growth
- SPRO N/A
- TOPP N/A
- EPS
- SPRO N/A
- TOPP N/A
- Revenue
- SPRO $44,584,000.00
- TOPP $16,117,227.00
- Revenue This Year
- SPRO N/A
- TOPP N/A
- Revenue Next Year
- SPRO N/A
- TOPP N/A
- P/E Ratio
- SPRO N/A
- TOPP N/A
- Revenue Growth
- SPRO N/A
- TOPP 0.44
- 52 Week Low
- SPRO $0.51
- TOPP $0.97
- 52 Week High
- SPRO $3.06
- TOPP $4.50
- Technical
- Relative Strength Index (RSI)
- SPRO 79.94
- TOPP N/A
- Support Level
- SPRO $2.81
- TOPP N/A
- Resistance Level
- SPRO $3.06
- TOPP N/A
- Average True Range (ATR)
- SPRO 0.24
- TOPP 0.00
- MACD
- SPRO -0.00
- TOPP 0.00
- Stochastic Oscillator
- SPRO 93.75
- TOPP 0.00
About SPRO Spero Therapeutics Inc.
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.
About TOPP TOPPOINT HOLDINGS INC
Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain. The company operates in one operating segment where it derives its revenues from the delivery of truckload services.